Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | 0.029 | 0.7 |
mRNA | OSI-906 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | AZD7762 | GDSC1000 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | oligomycin a | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | UNC0321 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | AZD7762 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | TAK-715 | GDSC1000 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | Nutlin-3a (-) | GDSC1000 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | BRD-K37390332 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |